Oncolytics Biotech
Price & Volume
Stats
See more52W Range | $0.46-$1.53 |
Market Cap | $49.7M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.29 |
News
See moreYahoo Finance • 3 months ago
Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus
Yahoo Finance • 2 years ago
Oncolytics Biotech's® Pelareorep Selected for Inclusion in Precision PromiseSM Pivotal Phase 3 Platform Trial
Yahoo Finance • 3 years ago
Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights
Yahoo Finance • 3 years ago
Oncolytics Biotech® Reports First Quarter 2022 Financial Results and Recent Operational Highlights
About
CEO | Mr. Wayne F. Pisano M.B.A. |
Address | 322 11th Avenue SW, Calgary, AB, Canada, T2R 0C5 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 28 |
